CONMED Corporation (CNMD) is a publicly traded Healthcare sector company. As of July 11, 2026, CNMD trades at $40.14 with a market cap of $1.10B and a P/E ratio of 24.74. CNMD moved +9.66% today. Year to date, CNMD is -5.22%; over the trailing twelve months it is -28.17%. Its 52-week range spans $31.44 to $78.00. Analyst consensus is neutral with an average price target of $38.74. Rallies surfaces CNMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
4 analysts cover CNMD: 0 strong buy, 0 buy, 3 hold, 1 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $38.74.
| Metric | Value |
|---|---|
| Price | $40.14 |
| Market Cap | $1.10B |
| P/E Ratio | 24.74 |
| EPS | $1.52 |
| Dividend Yield | 0.20% |
| 52-Week High | $78.00 |
| 52-Week Low | $31.44 |
| Volume | 1.06M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.37B |
| Net Income | $47.05M |
| Gross Margin | 54.59% |
4 analysts cover CNMD: 0 strong buy, 0 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $38.74.